QA: GERON CORP in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000886744_2023_GERON_CORP.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000886744, GERON CORP

  xvar xval
0 AssetsCurrent 180,246,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 793,000
3 remainder_Assets 9,536,000
4 LiabilitiesCurrent 76,694,000
5 LiabilitiesNoncurrent 33,883,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 43,628,000
9 ResearchAndDevelopmentExpense 95,518,000
10 remainder_Expenses 6,882,000
11 remainder_Revenues 596,000
12 remainder_NetIncome 3,531,000
13 remainder_ComprehensiveNetIncome -46,000
  yvar yval
0 Assets 190,575,000
1 Liabilities 110,577,000
2 Expenses 146,028,000
3 Revenues 596,000
4 StockholdersEquity 79,998,000
5 NetIncome -141,901,000
6 ComprehensiveNetIncome -141,924,000
7 BaseVar 225,676,500
8 EconomicCapitalRatio -0.0287

Edgar->Model Mapping

Feature Distribution

Change over Time